Travis K. Warren

6.8k total citations · 1 hit paper
54 papers, 2.9k citations indexed

About

Travis K. Warren is a scholar working on Infectious Diseases, Epidemiology and Emergency Medical Services. According to data from OpenAlex, Travis K. Warren has authored 54 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Infectious Diseases, 17 papers in Epidemiology and 11 papers in Emergency Medical Services. Recurrent topics in Travis K. Warren's work include Viral Infections and Outbreaks Research (42 papers), Viral Infections and Vectors (24 papers) and Viral gastroenteritis research and epidemiology (20 papers). Travis K. Warren is often cited by papers focused on Viral Infections and Outbreaks Research (42 papers), Viral Infections and Vectors (24 papers) and Viral gastroenteritis research and epidemiology (20 papers). Travis K. Warren collaborates with scholars based in United States, United Kingdom and Japan. Travis K. Warren's co-authors include Sina Bavari, Jay Wells, Rekha G. Panchal, Nicole L. Garza, Lisa S. Welch, Amy C. Shurtleff, Lián Dŏng, Sean A. Van Tongeren, Cary Retterer and Patrick L. Iversen and has published in prestigious journals such as Nature, New England Journal of Medicine and Nature Medicine.

In The Last Decade

Travis K. Warren

54 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430

2014 461 citations Travis K. Warren, Jay Wells et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Travis K. Warren United States	28	2.0k	843	514	308	295	54	2.9k
Chad E. Mire United States	38	2.5k 1.2×	1.5k 1.8×	627 1.2×	303 1.0×	279 0.9×	86	3.4k
Nicole L. Garza United States	19	1.1k 0.5×	459 0.5×	378 0.7×	159 0.5×	192 0.7×	25	1.6k
Martin J. Vincent United States	20	2.9k 1.5×	385 0.5×	398 0.8×	690 2.2×	217 0.7×	22	3.5k
Brian B. Gowen United States	34	2.8k 1.4×	1.1k 1.3×	669 1.3×	804 2.6×	224 0.8×	93	4.4k
Laura K. McMullan United States	22	1.9k 0.9×	508 0.6×	323 0.6×	529 1.7×	139 0.5×	30	2.5k
Hans-Dieter Klenk Germany	15	1.6k 0.8×	1.2k 1.5×	495 1.0×	113 0.4×	113 0.4×	17	2.6k
Gene G. Olinger United States	44	4.2k 2.1×	1.5k 1.8×	989 1.9×	469 1.5×	534 1.8×	91	5.8k
Bobbie R. Erickson United States	27	3.4k 1.7×	400 0.5×	296 0.6×	840 2.7×	272 0.9×	36	3.8k
Michael R. Holbrook United States	38	3.4k 1.7×	973 1.2×	661 1.3×	1.6k 5.3×	65 0.2×	107	4.6k
Cary Retterer United States	16	863 0.4×	359 0.4×	224 0.4×	182 0.6×	97 0.3×	24	1.3k

Countries citing papers authored by Travis K. Warren

Since Specialization

Citations

This map shows the geographic impact of Travis K. Warren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Travis K. Warren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Travis K. Warren more than expected).

Fields of papers citing papers by Travis K. Warren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Travis K. Warren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Travis K. Warren. The network helps show where Travis K. Warren may publish in the future.

Co-authorship network of co-authors of Travis K. Warren

This figure shows the co-authorship network connecting the top 25 collaborators of Travis K. Warren. A scholar is included among the top collaborators of Travis K. Warren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Travis K. Warren. Travis K. Warren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, David X., Bapi Pahar, Donna L. Perry, et al.. (2023). Depletion of Bone Marrow Hematopoietic Cells in Ebolavirus-Infected Rhesus Macaques. American Journal Of Pathology. 193(12). 2031–2046. 2 indexed citations

Bhosle, Sushma M., Shuǐqìng Yú, Ian Crozier, et al.. (2022). Duplex One-Step RT-qPCR Assays for Simultaneous Detection of Genomic and Subgenomic RNAs of SARS-CoV-2 Variants. Viruses. 14(5). 1066–1066. 3 indexed citations

Warren, Travis K., Christopher D. Kane, Jay Wells, et al.. (2021). Remdesivir is efficacious in rhesus monkeys exposed to aerosolized Ebola virus. Scientific Reports. 11(1). 19458–19458. 12 indexed citations

Porter, Danielle, Jessica M. Weidner, Laura Gomba, et al.. (2020). Remdesivir (GS-5734) Is Efficacious in Cynomolgus Macaques Infected With Marburg Virus. The Journal of Infectious Diseases. 222(11). 1894–1901. 50 indexed citations

Ward, Michael D., Ernst E. Brueggemann, Tara Kenny, et al.. (2019). Characterization of the plasma proteome of nonhuman primates during Ebola virus disease or melioidosis: a host response comparison. Clinical Proteomics. 16(1). 7–7. 6 indexed citations

Ma, Julia, Xuexiang Zhang, Veronica Soloveva, et al.. (2017). Enhancing the antiviral potency of ER α-glucosidase inhibitor IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo. Antiviral Research. 150. 112–122. 24 indexed citations

Bixler, Sandra L., Thomas Bocan, Jay Wells, et al.. (2017). Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus. Antiviral Research. 151. 97–104. 71 indexed citations

Bixler, Sandra L., Thomas Bocan, Jay Wells, et al.. (2017). Intracellular conversion and in vivo dose response of favipiravir (T-705) in rodents infected with Ebola virus. Antiviral Research. 151. 50–54. 33 indexed citations

Zeng, Xiankun, Candace D. Blancett, Keith A. Koistinen, et al.. (2017). Identification and pathological characterization of persistent asymptomatic Ebola virus infection in rhesus monkeys. Nature Microbiology. 2(9). 17113–17113. 90 indexed citations

10.

Harbourt, David E., et al.. (2016). Detection of Ebola Virus RNA through Aerosol Sampling of Animal Biosafety Level 4 Rooms Housing Challenged Nonhuman Primates. The Journal of Infectious Diseases. 215(4). jiw610–jiw610. 2 indexed citations

11.

Warfield, Kelly L., Travis K. Warren, Xiangguo Qiu, et al.. (2016). Assessment of the potential for host-targeted iminosugars UV-4 and UV-5 activity against filovirus infections in vitro and in vivo. Antiviral Research. 138. 22–31. 20 indexed citations

12.

Heald, Alison E., Jay S. Charleston, Patrick L. Iversen, et al.. (2015). AVI-7288 for Marburg Virus in Nonhuman Primates and Humans. New England Journal of Medicine. 373(4). 339–348. 40 indexed citations

13.

Warren, Travis K., John C. Trefry, Taylor Chance, et al.. (2014). Euthanasia Assessment in Ebola Virus Infected Nonhuman Primates. Viruses. 6(11). 4666–4682. 17 indexed citations

14.

Martins, Karen, Christopher L. Cooper, Travis K. Warren, et al.. (2014). Characterization of Clinical and Immunological Parameters During Ebola Virus Infection of Rhesus Macaques. Viral Immunology. 28(1). 32–41. 27 indexed citations

15.

Chang, Jinhong, Travis K. Warren, Xuesen Zhao, et al.. (2013). Small molecule inhibitors of ER α-glucosidases are active against multiple hemorrhagic fever viruses. Antiviral Research. 98(3). 432–440. 70 indexed citations

16.

Madrid, Peter B., Sidharth Chopra, Ian D. Manger, et al.. (2013). A Systematic Screen of FDA-Approved Drugs for Inhibitors of Biological Threat Agents. PLoS ONE. 8(4). e60579–e60579. 188 indexed citations

17.

Kugelman, Jeffrey R., Michael S. Lee, Cynthia A. Rossi, et al.. (2012). Ebola Virus Genome Plasticity as a Marker of Its Passaging History: A Comparison of In Vitro Passaging to Non-Human Primate Infection. PLoS ONE. 7(11). e50316–e50316. 34 indexed citations

18.

Warren, Travis K., Amy C. Shurtleff, & Sina Bavari. (2012). Advanced morpholino oligomers: A novel approach to antiviral therapy. Antiviral Research. 94(1). 80–88. 46 indexed citations

19.

Bolken, Tové C., Sylvie Laquerre, Yi Zhang, et al.. (2005). Identification and characterization of potent small molecule inhibitor of hemorrhagic fever New World arenaviruses. Antiviral Research. 69(2). 86–97. 83 indexed citations

20.

Warren, Travis K., Susan Amanda Lund, Kevin F. Jones, & Dennis E. Hruby. (2004). Development of PLEX, a plasmid-based expression system for production of heterologous gene products by the gram-positive bacteria Streptococcus gordonii. Protein Expression and Purification. 40(2). 319–326. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact